US EditionPublished • loading... • Updated
Aquis weekly movers: Shortwave Life Sciences plans clinical study
Summary by UK Investor Magazine
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Aquis weekly movers: Shortwave Life Sciences plans clinical study
Shortwave Life Sciences (LON: PSY), which is developing treatments for anorexia nervosa, is planning a clinical human feasibility study on impact of Psilocybin on the disease. This should lead to a phase 1 clinical study. A digital asset treasury strategy will help to fund the core business. The executive team is being changed. The share […] The post Aquis weekly movers: Shortwave Life Sciences plans clinical study appeared first on UK Investor …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
